To content
.
Investor Portal
Menu
Home
Team
Fund 3
News
Fund 3
ESG Disclosures
Contact
.
News
Vesalius News
05/31/2022
Memo Therapeutics: Clinical study
read more
03/29/2022
OncoDNA and Synlab: Partner
read more
03/29/2022
RejuvenateBiomed: Clinical Trial
read more
.
xxnoxx_zaehler